Global Mesalazine 麻豆原创 Growth 2025-2031

Publication ID:

LPI01253807

Publication Date:

January 29, 2025

Pages:

120

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Mesalazine market size is predicted to grow from US$ 182 million in 2025 to US$ 228 million in 2031; it is expected to grow at a CAGR of 3.8% from 2025 to 2031.
Mesalazine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The formulations which are taken by mouth appear to be similarly effective.
The global prevalence of IBD is rising, particularly in developed regions like North America and Europe, and increasingly in developing nations such as China and India. This increase is largely attributed to changes in lifestyle, dietary habits, and environmental factors, which are contributing to the growing demand for mesalazine.
With ulcerative colitis being the primary indication for mesalazine, the growing number of patients with this condition is directly driving market demand.
Global key players of Mesalazine are Syntese A/S, PharmaZell and Cambrex Corporation etc. The top 3 companies hold a share over 50%. The global Mesalazine are mainly produced in Europe and United States, they occupied for a share over 60%. Europe is the largest market, has a share about 43%, followed by Asia Pacific and North America, with share 31% and 12%, separately.
The 鈥淢esalazine Industry Forecast鈥� looks at past sales and reviews total world Mesalazine sales in 2024, providing a comprehensive analysis by region and market sector of projected Mesalazine sales for 2025 through 2031. With Mesalazine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mesalazine industry.
This Insight Report provides a comprehensive analysis of the global Mesalazine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mesalazine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Mesalazine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mesalazine and breaks down the forecast by Purity, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mesalazine.
This report presents a comprehensive overview, market shares, and growth opportunities of Mesalazine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Purity:
Above 97 %
Above 98 %
Above 99 %
Segmentation by Application:
Tablets
Capsules
Pellet and Granule
Suppository
Enema
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
PharmaZell
Syntese A/S
Cambrex Corporation
Divis Laboratories
Chemi SpA
Ipca Laboratories
Hangzhou Brother
Lianyungang Fengheng Biopharm
Lasa Loboratory
Corden Pharma Bergamo
Erregierre SpA
CTX Lifescience
Ishita Active Pharma Ingredients
YC Biotech (Jiangsu)
Key Questions Addressed in this Report
What is the 10-year outlook for the global Mesalazine market?
What factors are driving Mesalazine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mesalazine market opportunities vary by end market size?
How does Mesalazine break out by Purity, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Mesalazine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Mesalazine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Mesalazine by Country/Region, 2020, 2024 & 2031
2.2 Mesalazine Segment by Purity
2.2.1 Above 97 %
2.2.2 Above 98 %
2.2.3 Above 99 %
2.3 Mesalazine Sales by Purity
2.3.1 Global Mesalazine Sales 麻豆原创 Share by Purity (2020-2025)
2.3.2 Global Mesalazine Revenue and 麻豆原创 Share by Purity (2020-2025)
2.3.3 Global Mesalazine Sale Price by Purity (2020-2025)
2.4 Mesalazine Segment by Application
2.4.1 Tablets
2.4.2 Capsules
2.4.3 Pellet and Granule
2.4.4 Suppository
2.4.5 Enema
2.4.6 Others
2.5 Mesalazine Sales by Application
2.5.1 Global Mesalazine Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global Mesalazine Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global Mesalazine Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Mesalazine Breakdown Data by Company
3.1.1 Global Mesalazine Annual Sales by Company (2020-2025)
3.1.2 Global Mesalazine Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Mesalazine Annual Revenue by Company (2020-2025)
3.2.1 Global Mesalazine Revenue by Company (2020-2025)
3.2.2 Global Mesalazine Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Mesalazine Sale Price by Company
3.4 Key Manufacturers Mesalazine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mesalazine Product Location Distribution
3.4.2 Players Mesalazine Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Mesalazine by Geographic Region
4.1 World Historic Mesalazine 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Mesalazine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Mesalazine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Mesalazine 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Mesalazine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Mesalazine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Mesalazine Sales Growth
4.4 APAC Mesalazine Sales Growth
4.5 Europe Mesalazine Sales Growth
4.6 Middle East & Africa Mesalazine Sales Growth
5 Americas
5.1 Americas Mesalazine Sales by Country
5.1.1 Americas Mesalazine Sales by Country (2020-2025)
5.1.2 Americas Mesalazine Revenue by Country (2020-2025)
5.2 Americas Mesalazine Sales by Purity (2020-2025)
5.3 Americas Mesalazine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mesalazine Sales by Region
6.1.1 APAC Mesalazine Sales by Region (2020-2025)
6.1.2 APAC Mesalazine Revenue by Region (2020-2025)
6.2 APAC Mesalazine Sales by Purity (2020-2025)
6.3 APAC Mesalazine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Mesalazine by Country
7.1.1 Europe Mesalazine Sales by Country (2020-2025)
7.1.2 Europe Mesalazine Revenue by Country (2020-2025)
7.2 Europe Mesalazine Sales by Purity (2020-2025)
7.3 Europe Mesalazine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Mesalazine by Country
8.1.1 Middle East & Africa Mesalazine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Mesalazine Revenue by Country (2020-2025)
8.2 Middle East & Africa Mesalazine Sales by Purity (2020-2025)
8.3 Middle East & Africa Mesalazine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mesalazine
10.3 Manufacturing Process Analysis of Mesalazine
10.4 Industry Chain Structure of Mesalazine
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mesalazine Distributors
11.3 Mesalazine Customer
12 World Forecast Review for Mesalazine by Geographic Region
12.1 Global Mesalazine 麻豆原创 Size Forecast by Region
12.1.1 Global Mesalazine Forecast by Region (2026-2031)
12.1.2 Global Mesalazine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Mesalazine Forecast by Purity (2026-2031)
12.7 Global Mesalazine Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 PharmaZell
13.1.1 PharmaZell Company Information
13.1.2 PharmaZell Mesalazine Product Portfolios and Specifications
13.1.3 PharmaZell Mesalazine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 PharmaZell Main Business Overview
13.1.5 PharmaZell Latest Developments
13.2 Syntese A/S
13.2.1 Syntese A/S Company Information
13.2.2 Syntese A/S Mesalazine Product Portfolios and Specifications
13.2.3 Syntese A/S Mesalazine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Syntese A/S Main Business Overview
13.2.5 Syntese A/S Latest Developments
13.3 Cambrex Corporation
13.3.1 Cambrex Corporation Company Information
13.3.2 Cambrex Corporation Mesalazine Product Portfolios and Specifications
13.3.3 Cambrex Corporation Mesalazine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Cambrex Corporation Main Business Overview
13.3.5 Cambrex Corporation Latest Developments
13.4 Divis Laboratories
13.4.1 Divis Laboratories Company Information
13.4.2 Divis Laboratories Mesalazine Product Portfolios and Specifications
13.4.3 Divis Laboratories Mesalazine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Divis Laboratories Main Business Overview
13.4.5 Divis Laboratories Latest Developments
13.5 Chemi SpA
13.5.1 Chemi SpA Company Information
13.5.2 Chemi SpA Mesalazine Product Portfolios and Specifications
13.5.3 Chemi SpA Mesalazine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Chemi SpA Main Business Overview
13.5.5 Chemi SpA Latest Developments
13.6 Ipca Laboratories
13.6.1 Ipca Laboratories Company Information
13.6.2 Ipca Laboratories Mesalazine Product Portfolios and Specifications
13.6.3 Ipca Laboratories Mesalazine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Ipca Laboratories Main Business Overview
13.6.5 Ipca Laboratories Latest Developments
13.7 Hangzhou Brother
13.7.1 Hangzhou Brother Company Information
13.7.2 Hangzhou Brother Mesalazine Product Portfolios and Specifications
13.7.3 Hangzhou Brother Mesalazine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Hangzhou Brother Main Business Overview
13.7.5 Hangzhou Brother Latest Developments
13.8 Lianyungang Fengheng Biopharm
13.8.1 Lianyungang Fengheng Biopharm Company Information
13.8.2 Lianyungang Fengheng Biopharm Mesalazine Product Portfolios and Specifications
13.8.3 Lianyungang Fengheng Biopharm Mesalazine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Lianyungang Fengheng Biopharm Main Business Overview
13.8.5 Lianyungang Fengheng Biopharm Latest Developments
13.9 Lasa Loboratory
13.9.1 Lasa Loboratory Company Information
13.9.2 Lasa Loboratory Mesalazine Product Portfolios and Specifications
13.9.3 Lasa Loboratory Mesalazine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Lasa Loboratory Main Business Overview
13.9.5 Lasa Loboratory Latest Developments
13.10 Corden Pharma Bergamo
13.10.1 Corden Pharma Bergamo Company Information
13.10.2 Corden Pharma Bergamo Mesalazine Product Portfolios and Specifications
13.10.3 Corden Pharma Bergamo Mesalazine Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Corden Pharma Bergamo Main Business Overview
13.10.5 Corden Pharma Bergamo Latest Developments
13.11 Erregierre SpA
13.11.1 Erregierre SpA Company Information
13.11.2 Erregierre SpA Mesalazine Product Portfolios and Specifications
13.11.3 Erregierre SpA Mesalazine Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Erregierre SpA Main Business Overview
13.11.5 Erregierre SpA Latest Developments
13.12 CTX Lifescience
13.12.1 CTX Lifescience Company Information
13.12.2 CTX Lifescience Mesalazine Product Portfolios and Specifications
13.12.3 CTX Lifescience Mesalazine Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 CTX Lifescience Main Business Overview
13.12.5 CTX Lifescience Latest Developments
13.13 Ishita Active Pharma Ingredients
13.13.1 Ishita Active Pharma Ingredients Company Information
13.13.2 Ishita Active Pharma Ingredients Mesalazine Product Portfolios and Specifications
13.13.3 Ishita Active Pharma Ingredients Mesalazine Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Ishita Active Pharma Ingredients Main Business Overview
13.13.5 Ishita Active Pharma Ingredients Latest Developments
13.14 YC Biotech (Jiangsu)
13.14.1 YC Biotech (Jiangsu) Company Information
13.14.2 YC Biotech (Jiangsu) Mesalazine Product Portfolios and Specifications
13.14.3 YC Biotech (Jiangsu) Mesalazine Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 YC Biotech (Jiangsu) Main Business Overview
13.14.5 YC Biotech (Jiangsu) Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.